Godavari Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 765253, "name": "Godavari Drugs", "stock_name": "Godavari Drugs", "full_name": "Godavari Drugs Ltd", "name_url": "stocks-analysis/godavari-drugs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "124.00", "chg": 6.29, "chgp": "5.34%", "dir": 1, "prev_price": "117.71", "mcapval": "125.00 Cr", "mcap": "Micro Cap", "scripcode": 530317, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE362C01012", "curr_date": "Apr 17", "curr_time": "", "bse_nse_vol": "87.51 k", "exc_status": "Active", "traded_date": "Apr 17, 2026", "traded_date_str": "2026 04 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Godavari Drugs Ltd Surges 30.66%: Key Drivers Behind the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-surges-3066-key-drivers-behind-the-rally-3952457", "imagepath": "", "date": "2026-04-18 15:03:36", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock opens at Rs.100.43, surging 4.85% amid market weakness</p>\n <p><strong>14 Apr:</strong> Rating upgraded to Hold by MarketsMOJO on improved technicals</p>\n <p><strong>16 Apr:</strong> New 52-week high of Rs.120 reached with 11.57% daily gain</p>\n <p><strong>17 Apr:</strong> Further 52-week high at Rs.129.85, closing the week at Rs.125.15</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.100.43</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..." }, { "title": "Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 129.85", "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-hits-new-52-week-high-at-rs12985-3950418", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GodavariDrugsLt_priceRelatedfactors_3950418.png", "date": "2026-04-17 09:43:38", "description": "Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 129.85 on 17 Jun 2026, marking a significant milestone in its price momentum. This rally, driven by a confluence of technical indicators and sustained buying interest, has propelled the stock well above its 52-week low of Rs 69.70, delivering a 29.20% return over the past year against the Sensex’s modest decline of 0.60%." }, { "title": "Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 120", "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-hits-new-52-week-high-at-rs120-3949000", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GodavariDrugsLt_priceRelatedfactors_3949000.png", "date": "2026-04-16 10:05:54", "description": "Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 120 on 16 Jun 2026, marking a significant milestone in its recent price momentum. This breakout comes after a sustained seven-day rally that has propelled the stock up by over 30% in just one week, outpacing its sector and broader market indices." }, { "title": "Godavari Drugs Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3945183", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GodavariDrugsLt_mojoScore_3945183.png", "date": "2026-04-14 08:15:43", "description": "Godavari Drugs Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing challenges in financial performance. The upgrade, effective from 13 Apr 2026, is driven primarily by a bullish shift in technical trends and an attractive valuation relative to peers, while fundamental concerns remain subdued but persistent." }, { "title": "Godavari Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-by-marketsmojo-3935307", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GodavariDrugsLt_mojoScore_3935307.png", "date": "2026-04-07 10:10:02", "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Godavari Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-3919049", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_mojoScore_3919049.png", "date": "2026-03-27 10:10:03", "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Godavari Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-3893354", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_mojoScore_3893354.png", "date": "2026-03-16 10:10:02", "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Godavari Drugs Ltd Gains 6.83%: Technical Signals Drive Weekly Rally Amid Fundamental Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-gains-683-technical-signals-drive-weekly-rally-amid-fundamental-challenges-3891653", "imagepath": "", "date": "2026-03-14 17:04:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 02:</strong> Stock opens at Rs.75.58 amid broad market weakness</p>\n <p><strong>Mar 04:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>Mar 05:</strong> Upgrade to Sell rating on technical improvement</p>\n <p><strong>Mar 06:</strong> Stock surges 7.44% to close at Rs.83.02</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.75.58</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.83.02</div><di..." }, { "title": "Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-valuation-shifts-signal-renewed-price-attractiveness-3878824", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_valuationdot_3878824.png", "date": "2026-03-09 08:00:39", "description": "Godavari Drugs Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price metrics despite a challenging market backdrop. This article analyses the recent changes in the company’s price-to-earnings and price-to-book ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors." } ], "total": 173, "sid": "765253", "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253" }, "announcements": [ { "caption": "Clarification sought from Godavari Drugs Ltd", "datetime": "17-Apr-2026", "details": "The Exchange has sought clarification from Godavari Drugs Ltd on April 17 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "08-Apr-2026", "details": "Please find enclosed herewith intimation under Regulation 74(5) of SEBI (DP) Regulations 2015 for quarter ended March 2026", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "23-Mar-2026", "details": "Intimation of Trading Window Closure", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Apr: Stock opens at Rs.100.43, surging 4.85% amid market weakness

14 Apr: Rating upgraded to Hold by MarketsMOJO on improved technicals

16 Apr: New 52-week high of Rs.120 reached with 11.57% daily gain

17 Apr: Further 52-week high at Rs.129.85, closing the week at Rs.125.15

Week Open

Rs.100.43

Week Cl...

Read full news article

Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 129.85

2026-04-17 09:43:38

Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 129.85 on 17 Jun 2026, marking a significant milestone in its price momentum. This rally, driven by a confluence of technical indicators and sustained buying interest, has propelled the stock well above its 52-week low of Rs 69.70, delivering a 29.20% return over the past year against the Sensex’s modest decline of 0.60%.

Read full news article

Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 120

2026-04-16 10:05:54

Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 120 on 16 Jun 2026, marking a significant milestone in its recent price momentum. This breakout comes after a sustained seven-day rally that has propelled the stock up by over 30% in just one week, outpacing its sector and broader market indices.

Read full news article

Godavari Drugs Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-04-14 08:15:43

Godavari Drugs Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing challenges in financial performance. The upgrade, effective from 13 Apr 2026, is driven primarily by a bullish shift in technical trends and an attractive valuation relative to peers, while fundamental concerns remain subdued but persistent.

Read full news article

Godavari Drugs Ltd is Rated Sell by MarketsMOJO

2026-04-07 10:10:02

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Godavari Drugs Ltd is Rated Sell

2026-03-27 10:10:03

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Godavari Drugs Ltd is Rated Sell

2026-03-16 10:10:02

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Godavari Drugs Ltd Gains 6.83%: Technical Signals Drive Weekly Rally Amid Fundamental Challenges

2026-03-14 17:04:49

Key Events This Week

Mar 02: Stock opens at Rs.75.58 amid broad market weakness

Mar 04: Golden Cross formation signals potential bullish breakout

Mar 05: Upgrade to Sell rating on technical improvement

Mar 06: Stock surges 7.44% to close at Rs.83.02

Read full news article

Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-09 08:00:39

Godavari Drugs Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price metrics despite a challenging market backdrop. This article analyses the recent changes in the company’s price-to-earnings and price-to-book ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors.

Read full news article

View All News